health-and-legal1 day ago
GLP-1 Vision Loss Lawsuits Surge as NAION Claims Mount Against Eli Lilly, Novo Nordisk
Hundreds of lawsuits accuse GLP-1 manufacturers of failing to warn patients about NAION, a rare condition causing sudden vision loss. While drugmakers deny causation, plaintiffs argue labels in the U.S. lack warnings present in other countries. Experts note mixed evidence, with some studies showing a slight risk increase but emphasizing that absolute risk remains low and drug benefits often outweigh potential harms.